English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1574]
News [2092]
Articles [123]
Editorials [10]
Conferences [116]
elearning [20]
Ultrasound selectively damages cancer cells when tuned to correct frequencies
Ultrasound selectively damages cancer cells when tuned to correct frequencies
Women with single dose of HPV vaccine gain similar protection as multiple doses
Women with single dose of HPV vaccine gain similar protection as multiple doses
Scientists learn what women know, and don't know, about breast density and cancer risk
Scientists learn what women know, and don't know, about breast density and cancer risk
Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer
Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer
SABCS 2019: Predicting triple negative breast cancer recurrence
SABCS 2019: Predicting triple negative breast cancer recurrence
SABCS 2019: Oral paclitaxel yielded better outcomes than intravenous paclitaxel for metastatic breast cancer patients in phase III trial
SABCS 2019: Oral paclitaxel yielded better outcomes than intravenous paclitaxel for metastatic breast cancer...
SABCS 2019: Partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in patients with early breast cancer
SABCS 2019: Partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in...
SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients
SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients
ASH 2019: New drug markedly improves overall survival in patients with AML in remission
ASH 2019: New drug markedly improves overall survival in patients with AML in remission
ASH 2019: Combination therapy aimed at slowing the progression of a precursor myeloma condition
ASH 2019: Combination therapy aimed at slowing the progression of a precursor myeloma condition
<1...122123124125126...210>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top